Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: A multicenter study of 51 patients

Journal of Clinical Oncology

Volumn 18, Issue 4, 2000, Pages 788-794

  Morschhauser, F ^a   Cayuela, J M ^a   Martini, S ^a   Baruchel, A ^a   Rousselot, P ^a   Socie G ^a   Berthou, P ^a   Jouet, J P ^a   Straetmans, N ^a   Sigaux, F ^a   Fenaux, P ^a   Preudhomme, Claude ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; INTERLEUKIN 2;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW BIOPSY; CHILD; CHROMOSOME 21Q; CHROMOSOME 8Q; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN TISSUE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTICENTER STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

EID: 18744419375     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2000.18.4.788     Document Type: Article

References (25)

1. Nucifora G, Rowley J: AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86:1-14, 1995
2. Liu P, Harja A, Wijmenga C, et al: Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 85:2289-2302, 1995
3. Warrell RP, De Thé H, Wang ZY, et al: Acute promyelocytic leukemia. N Engl J Med 329:177-189, 1993
4. Martinelli G, Ottaviani E, Testoni N, et al: Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy. Haematologica 83:985-988, 1998
5. Marcucci G, Caligiuri MA, Bloomfield CD: Defining the "absence of the CBFbeta/MYH11 fusion transcript in patients with acute myeloid leukemia and inversion of chromosome 16 to predict long-term complete remission: A call for definitions. Blood 90:5022-5024, 1997
6. Nucifora G, Larson RA, Rowley JD: Persistence of the (8;21) translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 82:712-715, 1993
7. Kusec R, Laczika K, Knöbl P, et al: AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia 8:735-739, 1994
8. Miyamoto T, Nagafuji K, Akashi K, et al: Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with (8;21) acute myelogenous leukemia. Blood 87:4789-4796, 1996
9. Jurlander J, Caligiuri MA, Ruutu T, et al: Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood 88:2183-2191, 1996
10. Preudhomme C, Philippe N, Macintyre E, et al: Persistence of AML1/ETO fusion mRNA in t(8;21) acute myeloid leukemia (AML) in prolonged remission: Is there a consensus? Leukemia 10:186-188, 1996
11. Elmaagacli AH, Beelen DW, Stockova J, et al: Detection of AML1/ETO fusion transcripts in patients with (8;21) acute myeloid leukemia after allogeneic bone marrow transplantation of peripheral blood progenitor cell transplantation. Blood 90:3230-3236, 1997
12. Satake N, Maseki N, Kozu T, et al: Disappearance of AML1/ MTG8 (ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission. Br J Haematol 91:892-898, 1995
13. Mitelman F (ed): ISCN (1995): An International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger, 1995
14. Maseki N, Miyoshi H, Shimizu K, et al: The 8;21 chromosome translocation is always detectable by molecular analysis using AML1. Blood 81:1573-1579, 1993
15. Kozu T, Miyoshi H, Shimizu K, et al: Junctions of the AML1/MTG8 (ETO) fusion fusion are constant in t(8;21) acute myelopid leukemia detected by reverse transcription polymerase chain reaction. Blood 82:1270-1276, 1993
16. Downing JR, Head DR, Curcio-Brint AM, et al: An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8; 21)(q22;q22) translocation. Blood 81:2860-2865, 1993
17. Miyamoto T, Nagafuji K, Harada M, et al: Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cell harvests from patients with t(8;21) actue myelogenous lekaemia. Br J Haematol 91:132-138, 1995
18. Kwok S, Higuchi R: Avoiding false positives with PCR contamination. Nature 339:237-238, 1989
19. Dieffenbach CW, Dveksler GS: PCR Primer: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1995
20. Van Dongen JJ, Seriu T, Panzer-Grumayer ER, et al: Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 352:1731-1738, 1998
21. Diverio D, Rossi V, Avvisatit G, et al: Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. Blood 92:784-789, 1998
22. Baer MR, Stewart CC, Lawrence D, et al: Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22). Blood 90:1643-1648, 1997
23. Byrd JC, Weiss RB, Arthur DC, et al: Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): Results from Cancer and Leukemia Group B 8461. J Clin Oncol 15:466-475, 1997
24. Schoch C, Haase D, Haferlach T, et al: Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): An additional deletion in 9q is and adverse prognostic factor. Leukemia 10:1288-1295, 1996
25. Burnette ALK, Wheatley K, Langabeer S, et al: Outcome of acute myeloid leukaemias affecting core binding factor subunits: The UK MRC experience. Blood 90: 390a, 1997 (suppl 1, abstr)